Please login to the form below

Not currently logged in


This page shows the latest MDD news and features for those working in and with pharma, biotech and healthcare.

Acadia’s Nuplazid misses the mark in major depressive disorder trial

Acadia’s Nuplazid misses the mark in major depressive disorder trial

study for major depressive disorder (MDD), despite showing promise in an earlier, smaller trial. ... The schizophrenia trial, like the MDD trial, was viewed as one of Acadia’s biggest opportunities to extend the Nuplazid franchise – currently the

Latest news

More from news
Approximately 3 fully matching, plus 28 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...